British Journal of Cancer - Table of Contents alert Volume 113 Issue 8

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 113, Issue 8 (1133-1248) Published online 20 October 2015 In this issue Clinical Studies Translational Therapeutics Molecular Diagnostics Genetics & Genomics Also new today Advance online publication Digital Edition Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Introducing THE DARWIN CANCER BLOG — "keeping an evolutionary eye on cancer" led by Prof. Mel Greaves and brought to you by BJC. This blog provides a forum for discussing how an evolutionary perspective is changing thinking about cancer and aims to encourage discussion and debate among specialists and general interest readers. »Start reading the latest content Clinical Studies Top Aspirin as a neoadjuvant agent during preoperative chemoradiation for rectal cancer Angelo Restivo, Ivana Maria Francesca Cocco, Giuseppe Casula, Francesco Scintu, Francesco Cabras, Mario Scartozzi and Luigi Zorcolo Br J Cancer 2015 113: 1133-1139; advance online publication, September 15, 2015; 10.1038/bjc.2015.336 Abstract | Full Text A randomised, phase II study of nintedanib or sunitinib in previously untreated patients with advanced renal cell cancer: 3-year results T Eisen, A-B Loembé, Y Shparyk, N MacLeod, R J Jones, M Mazurkiewicz, G Temple, H Dressler and I Bondarenko Br J Cancer 2015 113: 1140-1147; advance online publication, October 8, 2015; 10.1038/bjc.2015.313 Abstract | Full Text Translational Therapeutics Top A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma Elodie Jobard, Ellen Blanc, Sylvie Négrier, Bernard Escudier, Gwenaelle Gravis, Christine Chevreau, Bénédicte Elena-Herrmann and Olivier Trédan Br J Cancer 2015 113: 1148-1157; advance online publication, September 15, 2015; 10.1038/bjc.2015.322 Abstract | Full Text Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol Yu-chi Shen, Ravi Upadhyayula, Stephanie Cevallos, Ryan J Messick, Tammy Hsia, Mathew P Leese, Douglas M Jewett, Daysha Ferrer-Torres, Therese M Roth, Wolfgang Dohle, Barry V L Potter and Kate F Barald Br J Cancer 2015 113: 1158-1167; advance online publication, October 13, 2015; 10.1038/bjc.2015.345 Abstract | Full Text Decomposition of spontaneous fluctuations in tumour oxygenation using BOLD MRI and independent component analysis Miguel R Gonçalves, S Peter Johnson, Rajiv Ramasawmy, R Barbara Pedley, Mark F Lythgoe and Simon Walker-Samuel Br J Cancer 2015 113: 1168-1177; 10.1038/bjc.2015.270 Abstract | Full Text Molecular Diagnostics Top HIF2α is involved in the expansion of CXCR4-positive cancer stem-like cells in renal cell carcinoma Carla Micucci, Giulia Matacchione, Debora Valli, Silvia Orciari and Alfonso Catalano Br J Cancer 2015 113: 1178-1185; advance online publication, October 6, 2015; 10.1038/bjc.2015.338 Abstract | Full Text Loss of FOXO1 promotes gastric tumour growth and metastasis through upregulation of human epidermal growth factor receptor 2/neu expression Young San Ko, Sung Jin Cho, Jinju Park, Younghoon Kim, Yong Joon Choi, Jung-Soo Pyo, Bo Gun Jang, Jong-Wan Park, Woo Ho Kim and Byung Lan Lee Br J Cancer 2015 113: 1186-1196; advance online publication, October 8, 2015; 10.1038/bjc.2015.273 Abstract | Full Text Automated prognostic pattern detection shows favourable diffuse pattern of FOXP3+ Tregs in follicular lymphoma Lilli S Nelson, James R Mansfield, Roslyn Lloyd, Kenneth Oguejiofor, Zena Salih, Lia P Menasce, Kim M Linton, Chris J Rose and Richard J Byers Br J Cancer 2015 113: 1197-1205; advance online publication, October 6, 2015; 10.1038/bjc.2015.291 Abstract | Full Text Prognostic value of the KRAS G12V mutation in 841 surgically resected Caucasian lung adenocarcinoma cases Stéphane Renaud, Pierre-Emmanuel Falcoz, Mickaël Schaëffer, Dominique Guenot, Benoit Romain, Anne Olland, Jérémie Reeb, Nicola Santelmo, Marie-Pierre Chenard, Michèle Legrain, Anne-Claire Voegeli, Michèle Beau-Faller and Gilbert Massard Br J Cancer 2015 113: 1206-1215; advance online publication, September 15, 2015; 10.1038/bjc.2015.327 Abstract | Full Text Metabolite profiling in retinoblastoma identifies novel clinicopathological subgroups Sarah Kohe, Marie-Anne Brundler, Helen Jenkinson, Manoj Parulekar, Martin Wilson, Andrew C Peet and Carmel M McConville on behalf of the Children's Cancer and Leukaemia Group (CCLG) Br J Cancer 2015 113: 1216-1224; advance online publication, September 8, 2015; 10.1038/bjc.2015.318 Abstract | Full Text PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients Elizabeth A Punnoose, Roberta Ferraldeschi, Edith Szafer-Glusman, Eric K Tucker, Sankar Mohan, Penelope Flohr, Ruth Riisnaes, Susana Miranda, Ines Figueiredo, Daniel Nava Rodrigues, Aurelius Omlin, Carmel Pezaro, Jin Zhu, Lukas Amler, Premal Patel, Yibing Yan, Natalee Bales, Shannon L Werner, Jessica Louw, Ajay Pandita, Dena Marrinucci, Gerhardt Attard and Johann de Bono Br J Cancer 2015 113: 1225-1233; advance online publication, September 17, 2015; 10.1038/bjc.2015.332 Abstract | Full Text S100A9 expressed in ER−PgR− breast cancers induces inflammatory cytokines and is associated with an impaired overall survival Caroline Bergenfelz, Alexander Gaber, Roni Allaoui, Meliha Mehmeti, Karin Jirström, Tomas Leanderson and Karin Leandersson Br J Cancer 2015 113: 1234-1243; advance online publication, October 8, 2015; 10.1038/bjc.2015.346 Abstract | Full Text Genetics & Genomics Top TERT promoter mutations are frequent and show association with MED12 mutations in phyllodes tumors of the breast Masayuki Yoshida, Reiko Ogawa, Hiroshi Yoshida, Akiko Maeshima, Yae Kanai, Takayuki Kinoshita, Nobuyoshi Hiraoka and Shigeki Sekine Br J Cancer 2015 113: 1244-1248; advance online publication, September 10, 2015; 10.1038/bjc.2015.326 Abstract | Full Text Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2015 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.